BAMCO INC /NY/ - 10X GENOMICS INC ownership

10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of 10X GENOMICS INC
ValueSharesWeighting
Q3 2023$7,463,197
+383.8%
180,926
+554.9%
0.02%
+450.0%
Q2 2023$1,542,636
+42.5%
27,626
+42.4%
0.00%
+33.3%
Q1 2023$1,082,326
+53.1%
19,4000.0%0.00%
+50.0%
Q4 2022$706,936
-92.1%
19,400
-93.8%
0.00%
-93.1%
Q3 2022$8,979,000
-51.1%
315,279
-22.3%
0.03%
-50.8%
Q2 2022$18,369,000
-34.3%
405,955
+10.5%
0.06%
-14.5%
Q1 2022$27,939,000
-68.7%
367,283
-38.8%
0.07%
-63.7%
Q4 2021$89,372,000
+5.1%
599,974
+2.7%
0.19%
-1.6%
Q3 2021$85,031,000
-26.0%
584,084
-0.5%
0.19%
-26.6%
Q2 2021$114,956,000
+6.8%
587,049
-1.3%
0.26%
-0.8%
Q1 2021$107,651,000
+27.4%
594,758
-0.4%
0.26%
+26.8%
Q4 2020$84,518,000
+39.2%
596,882
+22.6%
0.21%
+12.4%
Q3 2020$60,724,000
+60.5%
487,037
+14.9%
0.19%
+35.8%
Q2 2020$37,841,000
+166.9%
423,705
+86.2%
0.14%
+98.6%
Q1 2020$14,179,000
+23.0%
227,520
+50.5%
0.07%
+56.8%
Q4 2019$11,524,000
+51.8%
151,132
+0.4%
0.04%
+41.9%
Q3 2019$7,590,000150,6000.03%
Other shareholders
10X GENOMICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Venrock Management VI, LLC 8,185,565$952,538,00099.56%
Foresite Capital Management I, LLC 2,750,000$342,870,00096.54%
Foresite Capital Management II, LLC 3,503,528$436,820,00095.05%
12 West Capital Management LP 1,922,000$239,635,00011.66%
FINANCIAL CONSULATE, INC 163,366$20,368,0009.67%
JS Capital Management LLC 606,400$75,606,0003.91%
Asymmetry Capital Management, L.P. 43,512$5,425,0003.49%
Pinz Capital Management, LP 55,400$6,907,0002.52%
HAMILTON LANE ADVISORS LLC 37,087$4,624,0002.24%
RTW INVESTMENTS, LP 660,933$82,405,0001.98%
View complete list of 10X GENOMICS INC shareholders